BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
BioAv↑, BioAv↓,
BioAv↑, CYP1A1↓,
ROS↓, Inflam↓, TumCP↓, Apoptosis↑, *Dose↝, *BioAv↓, *BioAv↑, GSH↑, GSTs↑, PGE2↓, COX1↑, IL8↓, COX2↓, iNOS↓, NF-kB↓, chemoP↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
BioAv↑,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
antiOx↑, Inflam↓, AntiCan↓, other↝, BioAv↑, other↝,
Apoptosis↓, TumCCA↓, Inflam↓, TumMeta↓, BioAv↑, eff↓, Half-Life↓, *ROS↓, *RNS↓, *SOD↓, *Catalase↑, *GSTs↑, *MAOA↓, *neuroP↑, *DNAdam↓, Apoptosis↑, ROS↑, selectivity↑, MMP↓, Cyt‑c↓, Casp3↑, Casp9↑, TumCD↑, BAX↑, BAD↑, APAF1↑, Bcl-2↓, Bcl-xL↓, P53↑, cl‑PARP↑, TumCCA↑, cycD1/CCND1↓, CycB/CCNB1↓, CDK2↓, CDK4↓, P21↑, p27↑, NF-kB↓, COX2↓, PGE2↓, MAPK↓, PI3K↓, Akt↓, mTOR↓, MMPs↓, EMT↓, Snail↓, Slug↓, Zeb1↓, E-cadherin↑, ChemoSen↑,
| - |
in-vitro, |
GBM, |
A172 |
|
|
|
- |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
*BioAv↑, selectivity↑, AntiCan↑, Apoptosis↑, CHOP↑, GADD34↑, BIM↑, PUMA↑, Ca+2↝,
| - |
in-vivo, |
Colon, |
NA |
|
|
|
- |
Human, |
Nor, |
NA |
|
|
|
TumCG↓, HDAC↓, *BioAv↑, Dose∅, Half-Life∅,
| - |
in-vitro, |
Colon, |
Caco-2 |
|
|
|
P-gp↑, BioAv↑,
| - |
in-vitro, |
RCC, |
RCC4 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-435 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
Colon, |
SW48 |
|
|
|
- |
in-vitro, |
GBM, |
U251 |
|
|
|
eff↑, Warburg↓, BioAv↑, ROS↑, DNAdam↑, ATP↓, eff↑, necrosis↑, PARP↑,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, CYP1A1↓, 1, GSH↑, 1, GSTs↑, 1, ROS↓, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
Warburg↓, 1,
Cell Death ⓘ
Akt↓, 1, APAF1↑, 1, Apoptosis↓, 1, Apoptosis↑, 3, BAD↑, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, BIM↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↓, 1, GADD34↑, 1, iNOS↓, 1, MAPK↓, 1, necrosis↑, 1, p27↑, 1, PUMA↑, 1, TumCD↑, 1,
Transcription & Epigenetics ⓘ
other↝, 2,
Protein Folding & ER Stress ⓘ
CHOP↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1, PARP↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, P21↑, 1, TumCCA↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, HDAC↓, 1, mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2↝, 1, E-cadherin↑, 1, MMPs↓, 1, Slug↓, 1, Snail↓, 1, TumCP↓, 1, TumMeta↓, 1, Zeb1↓, 1,
Barriers & Transport ⓘ
P-gp↑, 1,
Immune & Inflammatory Signaling ⓘ
COX1↑, 1, COX2↓, 2, IL8↓, 1, Inflam↓, 3, NF-kB↓, 2, PGE2↓, 2,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 7, ChemoSen↑, 1, Dose∅, 1, eff↓, 1, eff↑, 2, Half-Life↓, 1, Half-Life∅, 1, selectivity↑, 2,
Functional Outcomes ⓘ
AntiCan↓, 1, AntiCan↑, 1, chemoP↑, 1,
Total Targets: 73
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GSTs↑, 1, RNS↓, 1, ROS↓, 1, SOD↓, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Synaptic & Neurotransmission ⓘ
MAOA↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 3, Dose↝, 1,
Functional Outcomes ⓘ
neuroP↑, 1,
Total Targets: 11
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:792 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page